Newark, NJ, United States of America

Alok K Choudhary

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alok K Choudhary. Retrieved from https://idiyas.com/inventor/alok-k-choudhary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alok K Choudhary: Innovator in Monoclonal Antibodies

Introduction

Alok K Choudhary is a prominent inventor based in Newark, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies for the diagnosis and treatment of infections. With a total of 4 patents to his name, Choudhary's work is paving the way for advancements in medical diagnostics and therapeutics.

Latest Patents

Choudhary's latest patents include innovative compositions, kits, vectors, and methods that utilize monoclonal antibodies directed to specific epitopes found within lipoarabinomannan (LAM) and phosphatidyl-myo-inositol mannoside 6 (PIM6). These inventions are crucial for the diagnosis and treatment of various infections, showcasing his commitment to improving healthcare outcomes.

Career Highlights

Choudhary is affiliated with Rutgers, the State University of New Jersey, where he continues to engage in groundbreaking research. His work has garnered attention in the scientific community, and he is recognized for his contributions to the understanding of infectious diseases.

Collaborations

Choudhary has collaborated with notable colleagues, including Abraham Pinter and Deendayal Patel. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Alok K Choudhary's contributions to the development of monoclonal antibodies represent a significant advancement in medical science. His innovative work continues to influence the diagnosis and treatment of infections, making a lasting impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…